EcoDrugPlus

Glutamate Ionotropic Receptor Kainate Type Subunit 1

Ensembl ID : ENSBTAG00000034854
Gene Symbol: GRIK1
7 Enzyme and pathways 5 Cross references
328 Possible Orthologues:

Glutamate Ionotropic Receptor Kainate Type Subunit 2

Ensembl ID : ENSBTAG00000033153
Gene Symbol: GRIK2
7 Enzyme and pathways 5 Cross references
346 Possible Orthologues:

Glutamate Ionotropic Receptor Kainate Type Subunit 3

Ensembl ID : ENSBTAG00000009269
Gene Symbol: GRIK3
7 Enzyme and pathways 5 Cross references
269 Possible Orthologues:

Glutamate Ionotropic Receptor Kainate Type Subunit 4

Ensembl ID : ENSBTAG00000017146
Gene Symbol: GRIK4
6 Enzyme and pathways 5 Cross references
275 Possible Orthologues:

Glutamate Ionotropic Receptor Kainate Type Subunit 5

Ensembl ID : ENSBTAG00000011723
Gene Symbol: GRIK5
6 Enzyme and pathways 5 Cross references
313 Possible Orthologues:

Glutamate Metabotropic Receptor 2

Ensembl ID : ENSBTAG00000001067
Gene Symbol: GRM2
6 Enzyme and pathways 5 Cross references
292 Possible Orthologues:

Glutamate Metabotropic Receptor 3

Ensembl ID : ENSBTAG00000018989
Gene Symbol: GRM3
6 Enzyme and pathways 5 Cross references
225 Possible Orthologues:

Glutamate Metabotropic Receptor 4

Ensembl ID : ENSBTAG00000013632
Gene Symbol: GRM4
6 Enzyme and pathways 5 Cross references
278 Possible Orthologues:

Glutamate Metabotropic Receptor 5

Ensembl ID : ENSBTAG00000048061
Gene Symbol: GRM5
9 Enzyme and pathways 5 Cross references
291 Possible Orthologues:

Glutaminase

Ensembl ID : ENSBTAG00000007863
Gene Symbol: GLS
12 Enzyme and pathways 5 Cross references
278 Possible Orthologues:

Glycogen Synthase Kinase 3 Alpha

Ensembl ID : ENSBTAG00000020756
Gene Symbol: GSK3A
5 Cross references
271 Possible Orthologues:

Glycogen Synthase Kinase 3 Beta

Ensembl ID : ENSBTAG00000048057
Gene Symbol: GSK3B
26 Enzyme and pathways 5 Cross references
256 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).